IBDEI0H6 ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,17247,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17247,1,3,0)
 ;;=3^Encntr for mntl hlth serv for perp of prntl child abuse
 ;;^UTILITY(U,$J,358.3,17247,1,4,0)
 ;;=4^Z69.011
 ;;^UTILITY(U,$J,358.3,17247,2)
 ;;=^5063229
 ;;^UTILITY(U,$J,358.3,17248,0)
 ;;=Z91.120^^73^872^38
 ;;^UTILITY(U,$J,358.3,17248,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17248,1,3,0)
 ;;=3^Pt's intent underdose of meds d/t financial hardship
 ;;^UTILITY(U,$J,358.3,17248,1,4,0)
 ;;=4^Z91.120
 ;;^UTILITY(U,$J,358.3,17248,2)
 ;;=^5063612
 ;;^UTILITY(U,$J,358.3,17249,0)
 ;;=Z91.128^^73^872^39
 ;;^UTILITY(U,$J,358.3,17249,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17249,1,3,0)
 ;;=3^Pt's intent underdose of meds d/t oth reasons
 ;;^UTILITY(U,$J,358.3,17249,1,4,0)
 ;;=4^Z91.128
 ;;^UTILITY(U,$J,358.3,17249,2)
 ;;=^5063613
 ;;^UTILITY(U,$J,358.3,17250,0)
 ;;=Z63.71^^73^872^44
 ;;^UTILITY(U,$J,358.3,17250,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17250,1,3,0)
 ;;=3^Stress on family d/t rtrn of family member from deployment
 ;;^UTILITY(U,$J,358.3,17250,1,4,0)
 ;;=4^Z63.71
 ;;^UTILITY(U,$J,358.3,17250,2)
 ;;=^5063171
 ;;^UTILITY(U,$J,358.3,17251,0)
 ;;=Z03.89^^73^873^1
 ;;^UTILITY(U,$J,358.3,17251,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17251,1,3,0)
 ;;=3^Observation for Suspected Diseases & Condition Ruled Out
 ;;^UTILITY(U,$J,358.3,17251,1,4,0)
 ;;=4^Z03.89
 ;;^UTILITY(U,$J,358.3,17251,2)
 ;;=^5062656
 ;;^UTILITY(U,$J,358.3,17252,0)
 ;;=E11.9^^73^874^11
 ;;^UTILITY(U,$J,358.3,17252,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17252,1,3,0)
 ;;=3^Type 2 DM w/o Complications
 ;;^UTILITY(U,$J,358.3,17252,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,17252,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,17253,0)
 ;;=E11.65^^73^874^9
 ;;^UTILITY(U,$J,358.3,17253,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17253,1,3,0)
 ;;=3^Type 2 DM w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,17253,1,4,0)
 ;;=4^E11.65
 ;;^UTILITY(U,$J,358.3,17253,2)
 ;;=^5002663
 ;;^UTILITY(U,$J,358.3,17254,0)
 ;;=E10.9^^73^874^6
 ;;^UTILITY(U,$J,358.3,17254,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17254,1,3,0)
 ;;=3^Type 1 DM w/o Complications
 ;;^UTILITY(U,$J,358.3,17254,1,4,0)
 ;;=4^E10.9
 ;;^UTILITY(U,$J,358.3,17254,2)
 ;;=^5002626
 ;;^UTILITY(U,$J,358.3,17255,0)
 ;;=E10.65^^73^874^4
 ;;^UTILITY(U,$J,358.3,17255,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17255,1,3,0)
 ;;=3^Type 1 DM w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,17255,1,4,0)
 ;;=4^E10.65
 ;;^UTILITY(U,$J,358.3,17255,2)
 ;;=^5002623
 ;;^UTILITY(U,$J,358.3,17256,0)
 ;;=E11.42^^73^874^7
 ;;^UTILITY(U,$J,358.3,17256,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17256,1,3,0)
 ;;=3^Type 2 DM w/ Diabetic Polyneuropathy
 ;;^UTILITY(U,$J,358.3,17256,1,4,0)
 ;;=4^E11.42
 ;;^UTILITY(U,$J,358.3,17256,2)
 ;;=^5002646
 ;;^UTILITY(U,$J,358.3,17257,0)
 ;;=E10.42^^73^874^2
 ;;^UTILITY(U,$J,358.3,17257,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17257,1,3,0)
 ;;=3^Type 1 DM w/ Diabetic Polyneuropathy
 ;;^UTILITY(U,$J,358.3,17257,1,4,0)
 ;;=4^E10.42
 ;;^UTILITY(U,$J,358.3,17257,2)
 ;;=^5002606
 ;;^UTILITY(U,$J,358.3,17258,0)
 ;;=E13.42^^73^874^1
 ;;^UTILITY(U,$J,358.3,17258,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17258,1,3,0)
 ;;=3^Secondary Type DM w/ Diabetic Polyneuropathy
 ;;^UTILITY(U,$J,358.3,17258,1,4,0)
 ;;=4^E13.42
 ;;^UTILITY(U,$J,358.3,17258,2)
 ;;=^5002686
 ;;^UTILITY(U,$J,358.3,17259,0)
 ;;=E10.621^^73^874^3
 ;;^UTILITY(U,$J,358.3,17259,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17259,1,3,0)
 ;;=3^Type 1 DM w/ Foot Ulcer
 ;;^UTILITY(U,$J,358.3,17259,1,4,0)
 ;;=4^E10.621
 ;;^UTILITY(U,$J,358.3,17259,2)
 ;;=^5002616
 ;;^UTILITY(U,$J,358.3,17260,0)
 ;;=E10.649^^73^874^5
 ;;^UTILITY(U,$J,358.3,17260,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17260,1,3,0)
 ;;=3^Type 1 DM w/ Hypoglycemia w/o Coma
 ;;^UTILITY(U,$J,358.3,17260,1,4,0)
 ;;=4^E10.649
 ;;^UTILITY(U,$J,358.3,17260,2)
 ;;=^5002622
 ;;^UTILITY(U,$J,358.3,17261,0)
 ;;=E11.621^^73^874^8
 ;;^UTILITY(U,$J,358.3,17261,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17261,1,3,0)
 ;;=3^Type 2 DM w/ Foot Ulcer
 ;;^UTILITY(U,$J,358.3,17261,1,4,0)
 ;;=4^E11.621
 ;;^UTILITY(U,$J,358.3,17261,2)
 ;;=^5002656
 ;;^UTILITY(U,$J,358.3,17262,0)
 ;;=E11.649^^73^874^10
 ;;^UTILITY(U,$J,358.3,17262,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17262,1,3,0)
 ;;=3^Type 2 DM w/ Hypoglycemia w/o Coma
 ;;^UTILITY(U,$J,358.3,17262,1,4,0)
 ;;=4^E11.649
 ;;^UTILITY(U,$J,358.3,17262,2)
 ;;=^5002662
 ;;^UTILITY(U,$J,358.3,17263,0)
 ;;=99211^^74^875^2
 ;;^UTILITY(U,$J,358.3,17263,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,17263,1,1,0)
 ;;=1^OFFICE VISIT
 ;;^UTILITY(U,$J,358.3,17263,1,2,0)
 ;;=2^99211
 ;;^UTILITY(U,$J,358.3,17264,0)
 ;;=99211^^74^876^1
 ;;^UTILITY(U,$J,358.3,17264,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,17264,1,1,0)
 ;;=1^F-T-F INTERVENTION
 ;;^UTILITY(U,$J,358.3,17264,1,2,0)
 ;;=2^99211
 ;;^UTILITY(U,$J,358.3,17265,0)
 ;;=99211^^74^877^1
 ;;^UTILITY(U,$J,358.3,17265,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,17265,1,1,0)
 ;;=1^CCHT VIDEO VISIT
 ;;^UTILITY(U,$J,358.3,17265,1,2,0)
 ;;=2^99211
 ;;^UTILITY(U,$J,358.3,17265,3,0)
 ;;=^358.33^1^1
 ;;^UTILITY(U,$J,358.3,17265,3,1,0)
 ;;=GT
 ;;^UTILITY(U,$J,358.3,17266,0)
 ;;=99078^^75^878^3^^^^1
 ;;^UTILITY(U,$J,358.3,17266,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,17266,1,2,0)
 ;;=2^99078
 ;;^UTILITY(U,$J,358.3,17266,1,3,0)
 ;;=3^GROUP HEALTH EDUCATION
 ;;^UTILITY(U,$J,358.3,17267,0)
 ;;=94760^^75^878^7^^^^1
 ;;^UTILITY(U,$J,358.3,17267,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,17267,1,2,0)
 ;;=2^94760
 ;;^UTILITY(U,$J,358.3,17267,1,3,0)
 ;;=3^PULSE OXIMETRY
 ;;^UTILITY(U,$J,358.3,17268,0)
 ;;=99080^^75^878^9^^^^1
 ;;^UTILITY(U,$J,358.3,17268,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,17268,1,2,0)
 ;;=2^99080
 ;;^UTILITY(U,$J,358.3,17268,1,3,0)
 ;;=3^SPECIAL REPORTS OR FORMS
 ;;^UTILITY(U,$J,358.3,17269,0)
 ;;=97535^^75^878^8^^^^1
 ;;^UTILITY(U,$J,358.3,17269,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,17269,1,2,0)
 ;;=2^97535
 ;;^UTILITY(U,$J,358.3,17269,1,3,0)
 ;;=3^SELF CARE MNGMENT TRAINING
 ;;^UTILITY(U,$J,358.3,17270,0)
 ;;=99366^^75^878^10^^^^1
 ;;^UTILITY(U,$J,358.3,17270,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,17270,1,2,0)
 ;;=2^99366
 ;;^UTILITY(U,$J,358.3,17270,1,3,0)
 ;;=3^TEAM CONF W/PAT BY HC PRO
 ;;^UTILITY(U,$J,358.3,17271,0)
 ;;=99499^^75^878^11^^^^1
 ;;^UTILITY(U,$J,358.3,17271,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,17271,1,2,0)
 ;;=2^99499
 ;;^UTILITY(U,$J,358.3,17271,1,3,0)
 ;;=3^UNLISTED E&M SERVICE
 ;;^UTILITY(U,$J,358.3,17272,0)
 ;;=G0108^^75^878^2^^^^1
 ;;^UTILITY(U,$J,358.3,17272,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,17272,1,2,0)
 ;;=2^G0108
 ;;^UTILITY(U,$J,358.3,17272,1,3,0)
 ;;=3^DM MGMT TRN PER INDIV PER 30MIN
 ;;^UTILITY(U,$J,358.3,17273,0)
 ;;=G0109^^75^878^1^^^^1
 ;;^UTILITY(U,$J,358.3,17273,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,17273,1,2,0)
 ;;=2^G0109
 ;;^UTILITY(U,$J,358.3,17273,1,3,0)
 ;;=3^DM MGMT TRN GRP PER 30MIN
 ;;^UTILITY(U,$J,358.3,17274,0)
 ;;=A9279^^75^878^5^^^^1
 ;;^UTILITY(U,$J,358.3,17274,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,17274,1,2,0)
 ;;=2^A9279
 ;;^UTILITY(U,$J,358.3,17274,1,3,0)
 ;;=3^MONITORING FEATURE/DEVICE NOC
 ;;^UTILITY(U,$J,358.3,17275,0)
 ;;=H0034^^75^878^4^^^^1
 ;;^UTILITY(U,$J,358.3,17275,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,17275,1,2,0)
 ;;=2^H0034
 ;;^UTILITY(U,$J,358.3,17275,1,3,0)
 ;;=3^MED TRNG & SUPPORT PER 15MIN
 ;;^UTILITY(U,$J,358.3,17276,0)
 ;;=S9445^^75^878^6^^^^1
 ;;^UTILITY(U,$J,358.3,17276,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,17276,1,2,0)
 ;;=2^S9445
 ;;^UTILITY(U,$J,358.3,17276,1,3,0)
 ;;=3^PT EDUCATION-INDIVIDUAL
 ;;^UTILITY(U,$J,358.3,17277,0)
 ;;=93005^^75^879^1^^^^1
 ;;^UTILITY(U,$J,358.3,17277,1,0)
 ;;=^358.31IA^3^2
